LEO MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LEO MED
Largest movements
- Cash +€90,561
up €90,561 (+76.9%), from €117,830 to €208,391
mainly Net result for the year (+€113,031) and Depreciation (+€648)
- Deferred charges and accrued income +€18,544
up €18,544 (+43.8%), from €42,302 to €60,846
- Receivables within one year +€4,395
up €4,395 (+94.9%), from €4,629 to €9,023
of which Other amounts receivable: +€5,182
- Reserves +€113,031
up €113,031 (+79.6%), from €141,937 to €254,969
- Gross operating margin -€37,525
down €37,525 (-20.3%), from €185,278 to €147,754
- Taxes -€9,185
down €9,185 (-22.2%), from €41,290 to €32,105
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €167,574 | €280,426 | +€112,852 | +67.3% |
| Fixed assets | 21/28 | €2,814 | €2,166 | -€648 | -23.0% |
| Tangible fixed assets | 22/27 | €2,814 | €2,166 | -€648 | -23.0% |
| Furniture and vehicles | 24 | €2,814 | €2,166 | -€648 | -23.0% |
| Current assets | 29/58 | €164,760 | €278,260 | +€113,500 | +68.9% |
| Amounts receivable within one year | 40/41 | €4,629 | €9,023 | +€4,395 | +94.9% |
| Trade receivables | 40 | €787 | - | -€787 | |
| Other amounts receivable | 41 | €3,841 | €9,023 | +€5,182 | +135% |
| Cash at bank and in hand | 54/58 | €117,830 | €208,391 | +€90,561 | +76.9% |
| Deferred charges and accrued income | 490/1 | €42,302 | €60,846 | +€18,544 | +43.8% |
| Total equity and liabilities | 10/49 | €167,574 | €280,426 | +€112,852 | +67.3% |
| Equity | 10/15 | €144,937 | €257,969 | +€113,031 | +78.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €141,937 | €254,969 | +€113,031 | +79.6% |
| Distributable reserves | 133 | €141,937 | €254,969 | +€113,031 | +79.6% |
| Amounts payable | 17/49 | €22,637 | €22,457 | -€179 | -0.8% |
| Amounts payable within one year | 42/48 | €22,637 | €22,457 | -€179 | -0.8% |
| Trade debts | 44 | €688 | €151 | -€537 | -78.0% |
| Suppliers | 440/4 | €688 | €151 | -€537 | -78.0% |
| Taxes, remuneration and social security | 45 | €21,949 | €22,306 | +€357 | +1.6% |
| Taxes | 450/3 | €21,949 | €22,306 | +€357 | +1.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €426 | €648 | +€222 | +52.1% |
| Other operating charges | 640/8 | €159 | €495 | +€335 | +211% |
| Gross operating margin | 9900 | €185,278 | €147,754 | -€37,525 | -20.3% |
| Operating profit (loss) | 9901 | €184,693 | €146,611 | -€38,082 | -20.6% |
| Financial charges | 65/66B | €1,466 | €1,476 | +€9 | +0.6% |
| Recurring financial charges | 65 | €1,466 | €1,476 | +€9 | +0.6% |
| Profit (loss) for the period before taxes | 9903 | €183,227 | €145,136 | -€38,091 | -20.8% |
| Income taxes | 67/77 | €41,290 | €32,105 | -€9,185 | -22.2% |
| Profit (loss) for the period | 9904 | €141,937 | €113,031 | -€28,906 | -20.4% |
| Profit (loss) for the period to be appropriated | 9905 | €141,937 | €113,031 | -€28,906 | -20.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.